<DOC>
	<DOCNO>NCT02352740</DOCNO>
	<brief_summary>The purpose study compare metabolic fate two oral form L-Arginine healthy subject feature metabolic syndrome relate risk factor</brief_summary>
	<brief_title>Characterization Metabolic Fate Oral Arginine Form</brief_title>
	<detailed_description>The study randomize crossover study include 16 healthy subject risk factor metabolic syndrome 16 healthy control subject . According double crossover design , subject receive two oral form L-arginine ( A B ) random order , participated exploration day first day arginine administration one week supplementation arginine form . The two week arginine supplementation separate washout period 2 week least . Each exploration extend 24 hour administration first arginine dose . Blood test perform 0 , 0.5 , 1 , 2 , 4 , 6 , 8 , 12 , 16 , 24 h administration first dose . During exploration supplementation period , also collect urine ( 0 , 2 , 4 , 8 , 12 , 24 h first dose ) .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Hypertriglyceridemic Waist</mesh_term>
	<criteria>Healthy subject 'Hypertriglyceridemic waist ' : Age 18 60 year old Overweight ( BMI 25 30 kg/m² ) 'Hypertriglyceridemic waist ' ( waist circumference &gt; 94cm men &gt; 88cm woman fast triglyceride level &gt; 150 mg/dL ) Obesity ( BMI &gt; 30 kg / m² ) Cardiac vascular disease Diabetes Thyroid disease Systolic blood pressure &gt; 150 mmHg diastolic blood pressure &gt; 90 mmHg Tobacco consumption &gt; 6 cigarette per week Alcohol consumption &gt; 3 drink per day Any medication ( except contraceptive treatment ) dietary supplement intake could arrest week first visit duration study . Persons guardianship Pregnancy ( positive betahCG blood test ) Positive serology HBsAg AcHbc , HCV HIV Hemoglobin &lt; 14 g/dl ( men ) &lt; 12 g / dl ( woman ) Participation clinical trial within 6 month precede study Healthy control subject : Age 18 60 year old Normal weight ( BMI 18.5 25 kg/m² ) Waist circumference &lt; 94cm men &lt; 88cm woman fast triglyceride level &lt; 150 mg/dL Exclusion Criteria : Cardiac vascular disease Diabetes Thyroid disease Systolic blood pressure &gt; 150 mmHg diastolic blood pressure &gt; 90 mmHg Tobacco consumption &gt; 6 cigarette per week Alcohol consumption &gt; 3 drink per day Any medication ( except contraceptive treatment ) dietary supplement intake could arrest week first visit duration study . Persons guardianship Pregnancy ( positive betahCG blood test ) Positive serology HBsAg AcHbc , HCV HIV Hemoglobin &lt; 14 g/dl ( men ) &lt; 12 g / dl ( woman ) Participation clinical trial within 6 month precede study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>arginine</keyword>
	<keyword>supplementation</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>nitric oxide</keyword>
</DOC>